Immunome Inc (IMNM)

SG&A Expense Growth

40.93%

Quarterly · Period ending:

IMNM logo

IMNM SG&A Expense Growth

Latest reported40.93%
IMNM Quarterly SG&A Growth (QoQ) (0.00% → 40.93%)
High-resolution chart · PNG

IMNM sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
40.9266%
7.1045%
10.4705%
8.9922%
-6.0617%
2.3358%
9.6578%
36.5148%
16.2032%
-25.3109%
83.7714%
1.2731%
47.8439%
-17.3409%
6.8299%
3.1162%
-10.2629%
3.3825%
7.757%
28.0415%
30.7091%
-14.2985%
90.6303%
42.6488%
52.4074%
18.4211%
-6.1728%
66.7238%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.